Lowell, MA - (July 8th, 2015) -- Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced the closing of its $16 million term loan facility with Solar Capital and $3 million revolving credit facility with Comerica Bank.The financing will provide Rapid Micro Biosystems working capital to support the continued global commercialization of its industry leading technology.
Jul 8, 2015 10:00:00 AM
Topics: Press Releases
Jun 23, 2015 10:00:00 AM
For many microbiology quality control labs, the budgeting process begins soon and the lab and other departments will begin the process of building their cases for new technology, manpower and other needs. Many quality control labs see the value of rapid micro methods (RMM) and must have a compelling case to include the new technologies in their final budget.
Building the case means clearly understanding and articulating the areas of potential benefit to your lab through the use of RMM. Following are four things to keep in mind as you craft your business case for an RMM in your budget.
Jun 5, 2015 8:00:00 AM
Kham Nguyen, Technical Services Manager at Rapid Micro Biosystems, recently presented an online seminar entitled, “Best Practices for Integrating Automated, Rapid Technology to LIMS." During the event he discussed reasons to integrate to LIMS, some of the options available, methods to engage IT and the validation impact of LIMS integration. In the below, short video Kham highlights some of the key points from his webinar.
May 13, 2015 8:30:00 AM
Last month, the Parenteral Drug Association's 2015 Annual Meeting was held in Las Vegas with the central theme of “Manufacturing Innovation and Efficiency: Achieving Quality Performance in Sterile and Biopharmaceutical Operations.” The meeting featured three main tracks to address industry challenges:
- Improving Manufacturing Performance
- Changing Regulatory Landscape
- Technology, Advances and Expectations
May 8, 2015 8:30:00 AM
At the 2015 PDA Annual Meeting in Las Vegas, the main tracks of the event included “Improving Manufacturing Performance”, “Changing Regulatory Landscape” and “Technology, Advances and Expectations” In the poster area of the event, Rapid Micro Biosystems presented a study entitled, “Sterility Testing: The Detection of Stressed Organisms in Seven Days” The poster is available here.
The poster identifies the results of a study using the Growth DirectTM Sterility Test in conjunction with a novel microbiological media, modified Schaedler Chocolate Broth (mSCB), to show detection of stressed microorganisms within seven days, reducing the length of traditional sterility tests by 50 percent.
Topics: Sterility Testing
May 6, 2015 9:00:00 AM
Lowell, MA- (May 6,2015) – Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, today announced the addition of Stephen Furlong as Chief Financial Officer (CFO). Mr. Furlong will lead the finance and accounting, information technology, and facilities functions for the business. He will report directly to the CEO, Robert Spignesi.
May 4, 2015 8:30:00 AM
Rapid Micro Biosystems is pleased to sponsor and exhibit at the 2015 European Microbiology Conference in Prague, Czech Republic on 6 and 7th of May. This year’s conference will focus on regulatory updates, contamination control, the use and validation of new microbiological methods and experiences from related industries.
Topics: Rapid Micro Biosystems
May 1, 2015 8:30:00 AM
If you are considering new pharmaceutical technologies or wondering about the regulations that govern their use, you won’t want to miss the International Society for Pharmaceutical Engineering’s 2015 Annual European Conference. This year’s conference, “Driving Effectiveness in Pharmaceutical Operations with Integrated Quality,” will take place May 4 through May 7 at the Steigenberger Airport Hotel in Frankfurt, Germany.
Apr 29, 2015 8:30:00 AM
Lowell, MA – April 29, 2015 – Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection for quality control testing within the pharmaceutical, personal care products and medical device market segments, today announced that it has raised $25 million in Series C equity financing. The financing will be used to expand global commercial and manufacturing operations in support of the industry leading Growth DirectTM System across the applications of environmental monitoring, sterility and bioburden testing.
Topics: Press Releases
Apr 28, 2015 10:34:00 AM
Are you interested in keeping up to date with the latest technologies and developments in pharmaceutical water and cleanroom verification? If so, you won’t want to miss the next series of Life Sciences User Group (LSUG) meetings - a free continuing education series for pharmaceutical quality professionals.